We read with interest the publication by Wang and colleagues on the off-label use of Mepolizumab for the treatment of eosinophilic cystitis in a 77-year-old patient [1].The authors presented another patient with idiopathic eosinophilic cystitis successfully treated with mepolizumab [1].
No takes yet. Share an insight, caveat, or question.
Tréfond et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: